Houston, China

Chen Qian

This inventor holds 1 USPTO granted patent. Top assignee: The Methodist Hospital System. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chen Qian. Retrieved from https://idiyas.com/inventor/chen-qian-5aeyqjt4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Chen Qian

Introduction

Chen Qian is a notable inventor based in Houston, China. He has made significant strides in the field of cancer research, particularly in the development of cancer vaccines and immunotherapy. His work is crucial in advancing medical science and improving treatment options for cancer patients.

Latest Patents

Chen Qian holds a patent titled "Cancer Neoantigens and Their Utilities in Cancer Vaccines and TCR-Based Cancer Immunotherapy." This patent highlights his innovative approach to utilizing neoantigens in the fight against cancer, showcasing his commitment to enhancing therapeutic strategies.

Career Highlights

Chen Qian is affiliated with The Methodist Hospital System, where he contributes to groundbreaking research in oncology. His work is characterized by a dedication to improving patient outcomes through innovative medical solutions. With a focus on cancer immunotherapy, he is at the forefront of developing new treatment modalities.

Collaborations

Chen collaborates with esteemed colleagues, including Yicheng Wang and Rongfu Wang. These partnerships enhance the research efforts and contribute to the advancement of cancer treatment methodologies.

Conclusion

In summary, Chen Qian is a pioneering inventor whose work in cancer research is making a significant impact. His patent and collaborations reflect his dedication to improving cancer treatment and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…